Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study
- Author:
Byungjin CHOI
1
;
Ah Ran OH
;
Jungchan PARK
;
Jong-Hwan LEE
;
Kwangmo YANG
;
Dong Yun LEE
;
Sang Youl RHEE
;
Sang-Soo KANG
;
Seung Do LEE
;
Sun Hack LEE
;
Chang Won JEONG
;
Bumhee PARK
;
Soobeen SEOL
;
Rae Woong PARK
;
Seunghwa LEE
Author Information
- Publication Type:Clinical Research Article
- From:Korean Journal of Anesthesiology 2024;77(1):66-76
- CountryRepublic of Korea
- Language:EN
-
Abstract:
Background:Perioperative adverse cardiac events (PACE), a composite of myocardial infarction, coronary revascularization, congestive heart failure, arrhythmic attack, acute pulmonary embolism, cardiac arrest, and stroke during 30-day postoperative period, is associated with long-term mortality, but with limited clinical evidence. We compared long-term mortality with PACE using data from nationwide multicenter electronic health records.
Methods:Data from 7 hospitals, converted to Observational Medical Outcomes Partnership Common Data Model, were used. We extracted records of 277,787 adult patients over 18 years old undergoing non-cardiac surgery for the first time at the hospital and had medical records for more than 180 days before surgery. We performed propensity score matching and then an aggregated meta‑analysis.
Results:After 1:4 propensity score matching, 7,970 patients with PACE and 28,807 patients without PACE were matched. The meta‑analysis showed that PACE was associated with higher one-year mortality risk (hazard ratio [HR]: 1.33, 95% CI [1.10, 1.60], P = 0.005) and higher three-year mortality (HR: 1.18, 95% CI [1.01, 1.38], P = 0.038). In subgroup analysis, the risk of one-year mortality by PACE became greater with higher-risk surgical procedures (HR: 1.20, 95% CI [1.04, 1.39], P = 0.020 for low-risk surgery; HR: 1.69, 95% CI [1.45, 1.96], P < 0.001 for intermediate-risk; and HR: 2.38, 95% CI [1.47, 3.86], P = 0.034 for high-risk).
Conclusions:A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.
